Portfolio (Quarterly)
Guide ↗
BML Capital Management, LLC
· CIK 0001616824| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACRS | ACLARIS THERAPEUTICS INC | Healthcare | 14,250,000.0 | $42.9M | 37.08% | NEW | — | $3.01 | +50.2% |
| 2 | AVIR | ATEA PHARMACEUTICALS INC | Healthcare | 7,490,000.0 | $26.7M | 23.11% | NEW | — | $3.57 | +23.8% |
| 3 | ORMP | ORAMED PHARMACEUTICALS INC | Healthcare | 3,167,231.0 | $9.0M | 7.80% | NEW | — | $2.85 | +40.0% |
| 4 | — | INSTIL BIO INC | — | 645,600.0 | $7.1M | 6.14% | NEW | — | $11.00 | — |
| 5 | PMVP | PMV PHARMACEUTICALS INC | Healthcare | 5,292,000.0 | $6.6M | 5.72% | NEW | — | $1.25 | +0.8% |
| 6 | KMX | CARMAX INC | Consumer Cyclical | 155,000.0 | $6.0M | 5.18% | NEW | — | $38.64 | +4.4% |
| 7 | — | KEZAR LIFE SCIENCES INC | — | 720,787.0 | $4.5M | 3.92% | NEW | — | $6.29 | — |
| 8 | TGT | TARGET CORP | Consumer Defensive | 37,500.0 | $3.7M | 3.17% | NEW | — | $97.75 | +28.5% |
| 9 | CVNA PUT | CARVANA CO | Consumer Cyclical | 150.0 | $2.0M | 1.74% | NEW | — | $13440.00 | -99.5% |
| 10 | OM | OUTSET MED INC | Healthcare | 543,180.0 | $2.0M | 1.74% | NEW | — | $3.71 | +16.4% |
| 11 | PLRX | PLIANT THERAPEUTICS INC | Healthcare | 1,546,137.0 | $1.9M | 1.63% | NEW | — | $1.22 | -0.8% |
| 12 | IMA | IMAGENEBIO INC | Healthcare | 177,026.0 | $1.2M | 1.06% | NEW | — | $6.90 | -19.4% |
| 13 | CNTB | CONNECT BIOPHARMA HLDGS LTD | Healthcare | 408,887.0 | $1.2M | 1.00% | NEW | — | $2.82 | -16.7% |
| 14 | WMT PUT | WALMART INC | Consumer Defensive | 335.0 | $492K | 0.43% | NEW | — | $1470.00 | -91.8% |
| 15 | TSLA PUT | TESLA INC | Consumer Cyclical | 1,000.0 | $205K | 0.18% | NEW | — | $205.00 | +107.8% |
| 16 | LSTA | LISATA THERAPEUTICS INC | Healthcare | 73,348.0 | $136K | 0.12% | NEW | — | $1.86 | +68.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
90.5%
Consumer Cyclical
5.9%
Consumer Defensive
3.6%